Eurobio Scientific SA - Asset Resilience Ratio

Latest as of June 2025: 10.52%

Eurobio Scientific SA (ALERS) has an Asset Resilience Ratio of 10.52% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check ALERS PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

€27.25 Million

≈ $31.86 Million USD Cash + Short-term Investments

Total Assets

€259.11 Million

≈ $302.92 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2007–2024)

This chart shows how Eurobio Scientific SA's Asset Resilience Ratio has changed over time. See Eurobio Scientific SA balance sheet quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Eurobio Scientific SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ALERS stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€26.86 Million	10.37%
Short-term Investments	€393.00K	0.15%
Total Liquid Assets	€27.25 Million	10.52%

Asset Resilience Insights

Moderate Liquidity: Eurobio Scientific SA has 10.52% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Eurobio Scientific SA Industry Peers by Asset Resilience Ratio

Compare Eurobio Scientific SA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Medacta Group SA SW:MOVE	Medical Devices	0.86%
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	Medical Devices	10.88%
Respiri Ltd AU:RSH	Medical Devices	0.46%
Human Xtensions Ltd TA:HUMX	Medical Devices	29.83%
Cochlear Ltd AU:COH	Medical Devices	9.76%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%

Annual Asset Resilience Ratio for Eurobio Scientific SA (2007–2024)

The table below shows the annual Asset Resilience Ratio data for Eurobio Scientific SA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	9.47%	€24.36 Million ≈ $28.47 Million	€257.17 Million ≈ $300.66 Million	-31.23pp
2023-12-31	40.70%	€128.76 Million ≈ $150.53 Million	€316.33 Million ≈ $369.82 Million	+3.06pp
2022-12-31	37.64%	€124.38 Million ≈ $145.41 Million	€330.42 Million ≈ $386.29 Million	-15.82pp
2021-12-31	53.46%	€111.85 Million ≈ $130.77 Million	€209.22 Million ≈ $244.61 Million	+15.15pp
2020-12-31	38.31%	€66.01 Million ≈ $77.18 Million	€172.30 Million ≈ $201.43 Million	+28.16pp
2019-12-31	10.15%	€8.22 Million ≈ $9.61 Million	€81.01 Million ≈ $94.70 Million	-7.19pp
2018-12-31	17.34%	€12.12 Million ≈ $14.17 Million	€69.90 Million ≈ $81.72 Million	-1.02pp
2017-12-31	18.36%	€13.14 Million ≈ $15.36 Million	€71.57 Million ≈ $83.68 Million	-8.91pp
2016-12-31	27.27%	€8.70 Million ≈ $10.17 Million	€31.89 Million ≈ $37.28 Million	+7.39pp
2015-12-31	19.88%	€7.10 Million ≈ $8.30 Million	€35.71 Million ≈ $41.75 Million	-7.64pp
2014-12-31	27.52%	€11.14 Million ≈ $13.03 Million	€40.50 Million ≈ $47.35 Million	+19.90pp
2013-12-31	7.62%	€2.55 Million ≈ $2.98 Million	€33.41 Million ≈ $39.06 Million	-0.55pp
2012-12-31	8.16%	€3.14 Million ≈ $3.67 Million	€38.49 Million ≈ $45.00 Million	-22.12pp
2011-12-31	30.28%	€5.33 Million ≈ $6.23 Million	€17.60 Million ≈ $20.58 Million	-35.12pp
2010-12-31	65.40%	€20.45 Million ≈ $23.90 Million	€31.26 Million ≈ $36.55 Million	-11.60pp
2009-12-31	77.00%	€28.14 Million ≈ $32.90 Million	€36.55 Million ≈ $42.73 Million	+25.39pp
2008-12-31	51.61%	€15.40 Million ≈ $18.01 Million	€29.85 Million ≈ $34.89 Million	-14.74pp
2007-12-31	66.34%	€24.94 Million ≈ $29.16 Million	€37.59 Million ≈ $43.95 Million	--

pp = percentage points

About Eurobio Scientific SA

PA:ALERS France Medical Devices

Market Cap

$261.31 Million

€223.52 Million EUR

Market Cap Rank

#15972 Global

#231 in France

Share Price

€22.20

Change (1 day)

+0.00%

52-Week Range

€20.60 - €25.70

All Time High

€28.88